[Evolution of diagnostic criteria for allergic bronchopulmonary aspergillosis]

Allergic bronchopulmonary aspergillosis (ABPA) is a lung disease characterized by sensitization to Aspergillus fumigatus. Patients often present with recurrent wheezing, fleeting pulmonary infiltrates, and bronchiectasis. Due to the atypical clinical manifestations, unclear pathogenesis, and lack of unified diagnostic criteria, ABPA is often misdiagnosed or overlooked. In 1977, Rosenberg criteria were introduced as the first diagnostic criteria for ABPA, but without further elaboration on the weighting of diagnostic items and thresholds. In 2013, the International Society for Human and Animal Mycology (ISHAM) proposed more specific diagnostic criteria. As the understanding of fungal sensitization disease has progressed, the concept of allergic bronchopulmonary mycosis (ABPM) has been proposed and has received increasing attention. In 2021, Asano et al. proposed the ABPM diagnostic criteria and found that their diagnostic sensitivity was superior to that of Rosenberg and ISHAM criteria. In 2024, ISHAM again revised the ABPA diagnostic criteria and proposed diagnostic criteria for ABPM. This article provided an analysis and interpretation of the diagnostic criteria for ABPA/ABPM in order to help the diagnosis and treatment of this disease.